Allianz Asset Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-15,205
| Closed | -$183K | – | 2096 |
|
|
2021
Q3 | $183K | Sell |
15,205
-4,500
| -23% | -$54.2K | ﹤0.01% | 1987 |
|
|
2021
Q2 | $417K | Sell |
19,705
-14,640
| -43% | -$310K | ﹤0.01% | 1729 |
|
|
2021
Q1 | $963K | Hold |
34,345
| – | – | ﹤0.01% | 1473 |
|
|
2020
Q4 | $893K | Sell |
34,345
-25,080
| -42% | -$652K | ﹤0.01% | 1493 |
|
|
2020
Q3 | $2.21M | Sell |
59,425
-1,326
| -2% | -$49.3K | ﹤0.01% | 1216 |
|
|
2020
Q2 | $3.12M | Buy |
60,751
+15,347
| +34% | +$788K | ﹤0.01% | 1144 |
|
|
2020
Q1 | $1.43M | Buy |
45,404
+5,482
| +14% | +$173K | ﹤0.01% | 1334 |
|
|
2019
Q4 | $2.38M | Buy |
+39,922
| New | +$2.38M | ﹤0.01% | 1404 |
|
|
2019
Q2 | – | Sell |
-31,078
| Closed | -$1.25M | – | 2223 |
|
|
2019
Q1 | $1.25M | Sell |
31,078
-12,389
| -29% | -$498K | ﹤0.01% | 1698 |
|
|
2018
Q4 | $1.97M | Sell |
43,467
-23,638
| -35% | -$1.07M | ﹤0.01% | 1474 |
|
|
2018
Q3 | $2.98M | Hold |
67,105
| – | – | ﹤0.01% | 1459 |
|
|
2018
Q2 | $2.63M | Buy |
67,105
+44,654
| +199% | +$1.75M | ﹤0.01% | 1432 |
|
|
2018
Q1 | $1.62M | Buy |
+22,451
| New | +$1.62M | ﹤0.01% | 1576 |
|
|
2015
Q4 | – | Sell |
-102,020
| Closed | -$2.41M | – | 1943 |
|
|
2015
Q3 | $2.41M | Buy |
102,020
+36,480
| +56% | +$861K | ﹤0.01% | 1274 |
|
|
2015
Q2 | $5.36M | Buy |
65,540
+373
| +0.6% | +$30.5K | 0.01% | 1112 |
|
|
2015
Q1 | $6.03M | Buy |
65,167
+30,600
| +89% | +$2.83M | 0.01% | 956 |
|
|
2014
Q4 | $1.4M | Buy |
+34,567
| New | +$1.4M | ﹤0.01% | 1359 |
|